Successful treatment of cytomegalovirus enteritis after unrelated allogeneic stem cell transplantation by the infusion of ex vivo-expanded CD4+ lymphocytes derived from the recipient's peripheral blood donor cells

Transpl Infect Dis. 2016 Feb;18(1):93-7. doi: 10.1111/tid.12487. Epub 2016 Jan 30.

Abstract

Adoptive immunotherapies have been developed for antiviral agent-refractory cytomegalovirus (CMV) disease after stem cell transplantation (SCT). However, the application of such strategies is limited, particularly in terms of need for donor cooperation regarding blood sampling and inaccessibility in the setting of cord blood transplantation. Herein, we describe the first successful treatment of antiviral agent-refractory CMV enteritis after allogeneic SCT by the infusion of ex vivo-expanded donor-derived CD4(+) lymphocytes obtained from the recipient's peripheral blood.

Keywords: CD4+ lymphocyte; allogeneic stem cell transplantation; cytomegalovirus enteritis; donor lymphocyte infusion.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Donors
  • CD4-Positive T-Lymphocytes / immunology*
  • Cytomegalovirus / isolation & purification*
  • Cytomegalovirus / physiology
  • Cytomegalovirus Infections / immunology*
  • Cytomegalovirus Infections / pathology
  • Cytomegalovirus Infections / virology*
  • Enteritis / drug therapy*
  • Humans
  • Male
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation / adverse effects*
  • Transplantation, Homologous / adverse effects
  • Virus Activation